Molina Healthcare Q2 GAAP EPS $5.35, adj. $5.65; raises full-year guidance

MOLINA HEALTHCARE, INC.

2023-Q2 EPS reported $10.87 revenue$16,476,000,000

GAAP EPS $5.35, adjusted EPS $5.65; net income $309M, up 24.6% YoY ($248M).
Premium revenue $8.04B, total revenue $8.33B; medical care ratio 87.5% improved from 88.1%.
Full-year 2023 EPS guidance raised; specific range not disclosed in filing excerpt.
G&A ratio 7.4% vs 6.8% prior year; after-tax margin 3.7% vs 3.1%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MOLINA HEALTHCARE, INC. reported the second quarter ended June 30, 2023 results: revenue $8,327, net income $309, EPS $5.35. Guidance raised.

Period: the second quarter ended June 30, 2023
Revenue: $8,327
Net income: $309
EPS: $5.35
Guidance: raised
Result: reported results

Exact text from the filing

Three months ended Six months ended June 30, June 30, 2023 2022 2023 2022 (In millions, except per-share results) Premium Revenue $8,042 $7,799 $15,927 $15,330 Total Revenue $8,327 $8,054 $16,476 $15,824 GAAP: Net Income $309 $248 $630 $506 EPS – Diluted $5.35 $4.25 $10.87 $8.63 Medical Care Ratio (MCR) 87.5 % 88.1 % 87.3 % 87.6 % G&A Ratio 7.4 % 6.8 % 7.3 %

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

MOLINA HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001179929-23-000095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.